JP2012524537A5 - - Google Patents

Download PDF

Info

Publication number
JP2012524537A5
JP2012524537A5 JP2012506544A JP2012506544A JP2012524537A5 JP 2012524537 A5 JP2012524537 A5 JP 2012524537A5 JP 2012506544 A JP2012506544 A JP 2012506544A JP 2012506544 A JP2012506544 A JP 2012506544A JP 2012524537 A5 JP2012524537 A5 JP 2012524537A5
Authority
JP
Japan
Prior art keywords
biological sample
pool
polynucleotide
tumor
expression level
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012506544A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012524537A (ja
JP5865241B2 (ja
Filing date
Publication date
Priority claimed from FR0901936A external-priority patent/FR2944805B1/fr
Application filed filed Critical
Publication of JP2012524537A publication Critical patent/JP2012524537A/ja
Publication of JP2012524537A5 publication Critical patent/JP2012524537A5/ja
Application granted granted Critical
Publication of JP5865241B2 publication Critical patent/JP5865241B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012506544A 2009-04-22 2010-04-21 肉腫の予後分子署名およびその使用 Expired - Fee Related JP5865241B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US17149509P 2009-04-22 2009-04-22
FR09/01936 2009-04-22
US61/171,495 2009-04-22
FR0901936A FR2944805B1 (fr) 2009-04-22 2009-04-22 Signature moleculaire pronostique des sarcomes et utilisations
PCT/FR2010/000323 WO2010122243A1 (fr) 2009-04-22 2010-04-21 Signature moléculaire pronostique des sarcomes et utilisations

Publications (3)

Publication Number Publication Date
JP2012524537A JP2012524537A (ja) 2012-10-18
JP2012524537A5 true JP2012524537A5 (https=) 2013-07-11
JP5865241B2 JP5865241B2 (ja) 2016-02-17

Family

ID=42077215

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012506544A Expired - Fee Related JP5865241B2 (ja) 2009-04-22 2010-04-21 肉腫の予後分子署名およびその使用

Country Status (6)

Country Link
US (1) US9708666B2 (https=)
EP (1) EP2473622A1 (https=)
JP (1) JP5865241B2 (https=)
CA (1) CA2759417C (https=)
FR (1) FR2944805B1 (https=)
WO (1) WO2010122243A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3064594A1 (en) 2015-03-06 2016-09-07 Université de Bordeaux Signature of clinical outcome in uterine smooth muscle tumor analysis, and method of diagnosis thereof
WO2017210662A1 (en) * 2016-06-03 2017-12-07 Castle Biosciences, Inc. Methods for predicting risk of recurrence and/or metastasis in soft tissue sarcoma
RU2625035C1 (ru) * 2016-09-06 2017-07-11 Федеральное государственное бюджетное учреждение "Ростовский научно-исследовательский онкологический институт" Министерства здравоохранения Российской Федерации Способ прогнозирования рецидивирования сарком мягких тканей
EP3530758A1 (en) 2018-02-23 2019-08-28 Université de Bordeaux Method for determining the in vitro presence of a target molecule in a biological sample, and its use for the in vitro analysis of cancers, in particular soft-tissue sarcomas and gastrointestinal stromal tumors

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2003295328A1 (en) * 2002-10-02 2004-04-23 Genentech, Inc. Compositions and methods for the diagnosis and treatment of tumor
US20040253606A1 (en) * 2002-11-26 2004-12-16 Protein Design Labs, Inc. Methods of detecting soft tissue sarcoma, compositions and methods of screening for soft tissue sarcoma modulators
US20080318803A1 (en) * 2004-05-27 2008-12-25 Vertex Pharmaceuticals Biomarkers for Monitoring Impdh Pathway Inhibition
EP1806413A1 (en) * 2006-01-06 2007-07-11 Oligene GmbH An in-vitro-method and means for determination of different tumor types and predicting success of surgical procedures in ovarian cancer
US8130007B2 (en) * 2006-10-16 2012-03-06 Formfactor, Inc. Probe card assembly with carbon nanotube probes having a spring mechanism therein

Similar Documents

Publication Publication Date Title
Esposito et al. Liquid biopsies for solid tumors: Understanding tumor heterogeneity and real time monitoring of early resistance to targeted therapies
Søreide et al. Evolving molecular classification by genomic and proteomic biomarkers in colorectal cancer: potential implications for the surgical oncologist
RU2014120427A (ru) Определение микрорнк в плазме для обнаружения ранних стадий колоректального рака
JP2012517241A5 (https=)
JP2017523810A5 (https=)
TWI456197B (zh) 作為早發性大腸直腸癌之生物標記的（ｌｉｎｅ－１低甲基化作用）
US20230127823A1 (en) Non-Invasive Gene Mutation Detection in Lung Cancer Patients
JP2009077712A5 (https=)
JP2010518811A5 (https=)
JP2014531573A5 (https=)
RU2015138992A (ru) Способы прогнозирования риска интерстициальной пневмонии
WO2010005991A3 (en) Circulating tumor and tumor stem cell detection using genomic specific probes
JP2014516543A5 (https=)
MX343863B (es) Conjunto de sondas de oligonucleotido y metodos para perfilado de microbiotica.
CN107849569B (zh) 肺腺癌生物标记物及其应用
JP2014518069A5 (https=)
JP2013178260A5 (https=)
JP2013518579A5 (https=)
RU2012133318A (ru) Идентификация, оценка и лечение раковых заболеваний с генетической или приобретенной устойчивостью к ингибиторам alk
JP2012524537A5 (https=)
EP3186394A1 (en) Treatment and detection of melanoma
CN104561287A (zh) 检测calr基因第9外显子突变的试剂和方法
Kunnath et al. Potential applications of circulating tumor DNA technology as a cancer diagnostic tool
Shin et al. Rapid and label-free amplification and detection assay for genotyping of cancer biomarker
TWI704927B (zh) 乾癬性關節炎的診斷及治療、與其之套組